Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 59

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 59
---
ISK FACTORS Before you vote, you should carefully consider the risks described below, and the risk factors described in the section entitled “Risk Factors” in Aptorum’s Annual Report on Form 20 -Ffor the year ended December 31, 2024, which is incorporated by reference into this proxy statement/prospectus. See the sections of this proxy statement/prospectus entitled “ Where You Can Find More Information” and “Cautionary Statement Regarding Forward -LookingStatements,” and the other information contained in this proxy statement/prospectus or in the documents of Aptorum incorporated by reference into this proxy statement/prospectus. In addition to those risks, new risks may emerge from time to time and it is not possible to predict all risk factors, nor can Aptorum or DiamiR assess the impact of all factors on the Merger and the Combined Company following the Merger or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in or implied by any forward -lookingstatements. Risks Related to the Merger If the Merger Agreement with DiamiR is not consummated, Aptorum’s share price could decline. The consummation of the Merger with DiamiR is subject to a number of closing conditions, including the completion of the Domestication, conversion of all outstanding convertible debt of ours and DiamiR’s, approval by our shareholders, completion of review by Nasdaq of Aptorum’s listing of additional securities application of the shares of common stock of the Combined Company to be issued in connection with the closing of the Merger, and other customary closing conditions. In addition, at the closing date of the Merger, Aptorum should maintain an aggregate amount of unrestricted cash and cash equivalents of not less than $2,260,000, and an amount of Working Capital (as defined in the Merger Agreement) of not less than $1,644,000. As of June30, 2025, Aptorum has approximately $2.8 million in cash and a current assets of approximately $3.0 million. We intend to address any shortfall through the execution of a public or private financing. The Company is targeting a closing of the transaction in the fourth quarter of 2025. If the DiamiR Merger is not consummated, Aptorum may be subject to a number of material risks, and its share price could be adversely affected, as follows: •Aptorum has incurred and expects to continue to incur significant expenses related to